(Q45933089)

18 December 2017

title

Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. (English)

1 reference

18 December 2017

0 references

0 references

1 reference

1 reference

1 reference

Gunnell J

1

1 reference

18 December 2017

Yeun JY

series ordinal

2

1 reference

18 December 2017

Depner TA

series ordinal

3

1 reference

18 December 2017

Kaysen GA

series ordinal

4

1 reference

18 December 2017

publication date

1 January 1999

1 reference

18 December 2017

American Journal of Kidney Diseases

published in

1 reference

18 December 2017

volume

33

1 reference

18 December 2017

issue

1

1 reference

18 December 2017

page(s)

63-72

1 reference

18 December 2017

USA multicenter clinical trial with recombinant human erythropoietin (Amgen). Results in hemodialysis patients

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970259-3

7 January 2021

R-HuEPO hyporesponsiveness--who and why?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970259-3

7 January 2021

Evidence-based recommendations for the clinical use of recombinant human erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970259-3

7 January 2021

Iron management in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970259-3

7 January 2021

Determinants of albumin concentration in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970259-3

7 January 2021

Acute phase proteins and peritoneal dialysate albumin loss are the main determinants of serum albumin in peritoneal dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970259-3

7 January 2021

Pathogenesis and treatment of the anemia of chronic disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970259-3

7 January 2021

Mechanisms of anemia in protein-energy malnutrition in Johannesburg.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970259-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970259-3

1 reference

7 January 2021

Ferritin synthesis in inflammation. II. Mechanism of increased ferritin synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970259-3

7 January 2021

The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970259-3

7 January 2021

High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970259-3

7 January 2021

The acute phase response and the hematopoietic system: the role of cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970259-3

7 January 2021

Human disease, free radicals, and the oxidant/antioxidant balance

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970259-3

7 January 2021

Reactive oxygen species and iron--a dangerous partnership in inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970259-3

7 January 2021

Effect of intravenous iron dextran on rheumatoid synovitis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970259-3

7 January 2021

MECHANISM OF EXACERBATION OF RHEUMATOID SYNOVITIS BY TOTAL-DOSE IRON-DEXTRAN INFUSION: IN-VIVO DEMONSTRATION OF IRON-PROMOTED OXIDANT STRESS

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970259-3

7 January 2021

Effect of iron complexes on adjuvant arthritis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970259-3

7 January 2021

Recombinant human erythropoietin: implications for nephrology

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970259-3

7 January 2021

Occult infection and resistance of anaemia to rHuEpo therapy in renal failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970259-3

7 January 2021

Elevated circulating levels of interleukin-6 in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970259-3

7 January 2021

Inflammatory effects of peritoneal dialysis: evidence of systemic monocyte activation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970259-3

7 January 2021

Elevated serum levels of C-reactive protein in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970259-3

7 January 2021

Serum interleukin-6 in long-term hemodialyzed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970259-3

7 January 2021

Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970259-3

7 January 2021

Effects of gender and age on thixotropic properties of whole blood from healthy adult subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970259-3

7 January 2021

Intravenous versus subcutaneous dosing of epoetin: a review of the literature.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970259-3

7 January 2021

10.1016/S0272-6386(99)70259-3

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017